Kieran Williams PhD

Kieran is a Registered Australian and New Zealand Patent Attorney practicing in the fields of biotechnology, pharmaceuticals, neurobiology, immunology, molecular biology, stem cell biology and plant breeder’s rights.

Kieran has extensive experience in:

• Drafting patent specifications
• Filing and prosecuting local and foreign patent applications
• Preparing and prosecuting applications for pharmaceutical patent term extensions
• Preparing patent validity and infringement advice, and freedom to operate opinions
• Conducting patent oppositions
• Patent watching and searching
• Filing and prosecuting plant breeder’s rights applications.

Prior to joining Shelston IP, Kieran was a Patent Examiner at IP Australia, a Clinical Pharmacology Scientist at GlaxoSmithKline Australia, and has held Postdoctoral Fellowships at St Vincent’s Hospital in Australia, the Max Planck Institute of Neurobiology in Germany and the University of Aberdeen in Scotland.

Kieran has been recommended in the 2019 Intellectual Asset Management (IAM Patent 1000 2019) “Both Kieran Williams and Grant Shoebridge are intimately familiar with patent term extensions and plant breeder’s rights and are the outfit’s resident biotech and pharmaceuticals authorities. Williams has an assured hand when it comes to overseeing complicated instructions thanks to former stints as a patent examiner at IP Australia and as a clinical pharmacology scientist at GlaxoSmithKline”

Qualifications

• Registered Patent Attorney (Australia and New Zealand)
• Registered Trade Mark Attorney (Australia)
• Doctor of Philosophy (Neuroscience), University of Sydney
• Bachelor of Science (Honours), University of Sydney
• Master of Industrial Property, University of Technology Sydney.

Associations

• Fellow, Institute of Patent and Trade Mark Attorneys of Australia
• Intellectual Property Society of Australia and New Zealand
• Australian Biotechnology Association (AusBiotech)
• Asian Patent Attorneys Association (APAA).

2017 Biotechnology awards